Evolution of the Average Target: Coupang, Inc.

Evolution of the Target Price: Coupang, Inc.

Changes in Analyst Recommendations: Coupang, Inc.

7e05ae9.5lwLDHi3KcY4ocuxYFYsB8dEmnvD4q6ClgY3EY2BphU.tTFRO0zHW7Ne7rnpLSFEVYAJzkysocPW7kJVKO_N5UerJGxKM8Zev1_Mgg~c8a677a28c1edd73b71cb73a13224f1d
01-16 Deutsche Bank Upgrades Coupang to Buy From Hold, Adjusts Price Target to $25 From $29 MT
01-13 Coupang Shares Fall After Nomura Downgrade MT
01-13 Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30 MT
01-13 Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30 MT
12-17 Nomura Adjusts Coupang Price Target to $30 From $38, Maintains Buy Rating MT
18/09/25 Arete Initiates Coverage on Coupang With Buy Rating, $40 Price Target MT
11/09/25 On the stock market, inflation pushes Oracle off the front page. Zonebourse
20/08/25 Coupang's Growing Taiwan Business to Drive Long-term Growth, Morgan Stanley Says MT
20/08/25 Morgan Stanley Lifts Price Target on Coupang to $35 From $32, Keeps Overweight Rating MT
06/08/25 Deutsche Bank Downgrades Coupang to Hold From Buy, Price Target is $27 MT
05/08/25 Coupang Q2 revenue up 16%, beats analyst expectations RE
27/05/25 Coupang to Meet 2025 Growth Targets as Market Share Gains Continue, Morgan Stanley Says MT
27/05/25 Morgan Stanley Raises Price Target on Coupang to $32 From $27, Keeps Overweight Rating MT
26/02/25 Deutsche Bank Upgrades Coupang to Buy From Hold MT
07/10/24 Bernstein Upgrades Coupang to Outperform From Underperform, Price Target is $30 MT
16/05/24 UBS Upgrades Coupang to Buy From Neutral MT
09/05/24 Barclays Adjusts Price Target on Coupang to $32 From $25, Maintains Overweight Rating MT
08/05/24 Mizuho Adjusts Coupang's Price Target to $23 From $20, Keeps Neutral Rating MT
16/04/24 Nomura Raises Price Target on Coupang to $26 From $21 on Increased Membership Fee, Keeps Buy Rating MT
15/04/24 Coupang Remains Top Pick Following Membership Fee Increase, Morgan Stanley Says MT
15/04/24 Citigroup Upgrades Coupang to Buy From Neutral, Adjusts Price Target to $26 From $19 MT
15/04/24 Morgan Stanley Lifts Price Target on Coupang to $26 From $24 to Reflect WOW Membership Price Increase; Overweight Kept MT
20/03/24 Coupang Insider Sold Shares Worth $2,538,210, According to a Recent SEC Filing MT
29/02/24 Barclays Adjusts Price Target on Coupang to $25 From $24, Maintains Overweight Rating MT
20/12/23 UBS Downgrades Coupang to Neutral From Buy, Adjusts Price Target to $18.50 From $26 MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+57.83%
+23.46%
+42.43%
-0.68%
+28.92%
-1.71%
+9.18%
+8.35%
- - - -2.36%
-4.23%
Average +16.12%
Weighted average by Cap. +23.91%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
21.13USD
Average target price
33.35USD
Spread / Average Target
+57.83%
High Price Target
40.00USD
Spread / Highest target
+89.30%
Low Price Target
22.00USD
Spread / Lowest Target
+4.12%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
Nomura
Arete
Morgan Stanley
Bernstein
UBS
Barclays
Mizuho Securities
Citigroup
BofA Securities
New Street
Autonomous Research
HSBC
Macquarie
Credit Suisse
Goldman Sachs
Daiwa Securities
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
21.13USD
Average target price
33.35USD
Spread / Average Target
+57.83%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CPNG Stock
  4. Consensus Coupang, Inc.